These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9624510)

  • 21. Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N
    Ourghanlian C; Soroka D; Arthur M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
    Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC
    Microbios; 1993; 76(309):251-61. PubMed ID: 8302203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1983 Sep; 24(3):429-31. PubMed ID: 6416162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
    J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition.
    Elings W; Tassoni R; van der Schoot SA; Luu W; Kynast JP; Dai L; Blok AJ; Timmer M; Florea BI; Pannu NS; Ubbink M
    Biochemistry; 2017 Nov; 56(47):6257-6267. PubMed ID: 29087696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
    Wivagg CN; Bhattacharyya RP; Hung DT
    J Antibiot (Tokyo); 2014 Sep; 67(9):645-54. PubMed ID: 25052484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis.
    Nadler JP; Berger J; Nord JA; Cofsky R; Saxena M
    Chest; 1991 Apr; 99(4):1025-6. PubMed ID: 1901260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    Cavanaugh JS; Jou R; Wu MH; Dalton T; Kurbatova E; Ershova J; Cegielski JP;
    J Antimicrob Chemother; 2017 Jun; 72(6):1678-1687. PubMed ID: 28333192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of beta-lactamase activities and antibiotic susceptibility of some Bacillus strains causing food poisoning.
    Uraz G; Simşek H; Maraş Y
    Drug Metabol Drug Interact; 2001; 18(1):69-77. PubMed ID: 11522126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
    Wang F; Cassidy C; Sacchettini JC
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
    Pagliotto AD; Caleffi-Ferracioli KR; Lopes MA; Baldin VP; Leite CQ; Pavan FR; Scodro RB; Siqueira VL; Cardoso RF
    J Microbiol Immunol Infect; 2016 Dec; 49(6):980-983. PubMed ID: 26454420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B; Soubirou JF; Chau F; Massias L; Dion S; Lepeule R; Fantin B; Lefort A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning, overexpression and biochemical characterization of hypothetical beta-lactamases of Mycobacterium tuberculosis H37Rv.
    Nampoothiri KM; Rubex R; Patel AK; Narayanan SS; Krishna S; Das SM; Pandey A
    J Appl Microbiol; 2008 Jul; 105(1):59-67. PubMed ID: 18217931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
    Sirot D; Chanal C; Henquell C; Labia R; Sirot J; Cluzel R
    J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase Inhibitors.
    Nguyen TV; Blackledge MS; Lindsey EA; Minrovic BM; Ackart DF; Jeon AB; Obregón-Henao A; Melander RJ; Basaraba RJ; Melander C
    Angew Chem Int Ed Engl; 2017 Mar; 56(14):3940-3944. PubMed ID: 28247991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.